Shehzad M Malik, MD | |
1249 S Cedar Crest Blvd, Suite100, Allentown, PA 18103-6259 | |
(610) 770-2200 | |
(610) 776-6645 |
Full Name | Shehzad M Malik |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 23 Years |
Location | 1249 S Cedar Crest Blvd, Allentown, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215153192 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | MD427173 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jfk Medical Center | Edison, NJ | Hospital |
Lehigh Valley Hospital | Allentown, PA | Hospital |
St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Heart Care Group Pc | 8325947062 | 5 |
Hackensack Meridian Health Medical Group - Primary Care Pc | 7911003330 | 273 |
Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
News Archive
Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that clinical data featuring its Precision Cancer MonitoringSM platform will be presented at the 2015 Cancer Markers and Liquid Biopsies conference in San Diego, CA on June 11-12, and at the AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy in Salt Lake City, UT on June 13-16.
More than a month into President Joe Biden's term, nominees to fill some of the top posts at the Department of Health and Human Services are finally getting confirmation hearings in the Senate, starting with the nominee for secretary, California Attorney General Xavier Becerra.
Corning Incorporated today introduced the Corning® Synthemax™ surface, a novel synthetic surface that supports the growth and differentiation of stem cells. The surface is being commercialized as a result of Corning's ongoing collaboration with Geron Corporation. This development enables researchers to take the next step toward scalable and cost-effective manufacturing of stem cells for potential therapies in the treatment of degenerative diseases.
Today, the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) publish their jointly developed European Union Standards for Tuberculosis Care.
New data from HIMSS Analytics indicates that 44 percent of hospital respondents fall within the "Likely" or "Most Likely" categories for meeting Stage 1 of meaningful use.
› Verified 1 days ago
Entity Name | The Heart Care Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700967916 PECOS PAC ID: 8325947062 Enrollment ID: O20040102000108 |
News Archive
Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that clinical data featuring its Precision Cancer MonitoringSM platform will be presented at the 2015 Cancer Markers and Liquid Biopsies conference in San Diego, CA on June 11-12, and at the AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy in Salt Lake City, UT on June 13-16.
More than a month into President Joe Biden's term, nominees to fill some of the top posts at the Department of Health and Human Services are finally getting confirmation hearings in the Senate, starting with the nominee for secretary, California Attorney General Xavier Becerra.
Corning Incorporated today introduced the Corning® Synthemax™ surface, a novel synthetic surface that supports the growth and differentiation of stem cells. The surface is being commercialized as a result of Corning's ongoing collaboration with Geron Corporation. This development enables researchers to take the next step toward scalable and cost-effective manufacturing of stem cells for potential therapies in the treatment of degenerative diseases.
Today, the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) publish their jointly developed European Union Standards for Tuberculosis Care.
New data from HIMSS Analytics indicates that 44 percent of hospital respondents fall within the "Likely" or "Most Likely" categories for meeting Stage 1 of meaningful use.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Shehzad M Malik, MD 1249 S Cedar Crest Blvd, Ste 100, Allentown, PA 18103-6200 Ph: (610) 770-2200 | Shehzad M Malik, MD 1249 S Cedar Crest Blvd, Suite100, Allentown, PA 18103-6259 Ph: (610) 770-2200 |
News Archive
Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that clinical data featuring its Precision Cancer MonitoringSM platform will be presented at the 2015 Cancer Markers and Liquid Biopsies conference in San Diego, CA on June 11-12, and at the AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy in Salt Lake City, UT on June 13-16.
More than a month into President Joe Biden's term, nominees to fill some of the top posts at the Department of Health and Human Services are finally getting confirmation hearings in the Senate, starting with the nominee for secretary, California Attorney General Xavier Becerra.
Corning Incorporated today introduced the Corning® Synthemax™ surface, a novel synthetic surface that supports the growth and differentiation of stem cells. The surface is being commercialized as a result of Corning's ongoing collaboration with Geron Corporation. This development enables researchers to take the next step toward scalable and cost-effective manufacturing of stem cells for potential therapies in the treatment of degenerative diseases.
Today, the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) publish their jointly developed European Union Standards for Tuberculosis Care.
New data from HIMSS Analytics indicates that 44 percent of hospital respondents fall within the "Likely" or "Most Likely" categories for meeting Stage 1 of meaningful use.
› Verified 1 days ago
Jessica Mary Boehmler, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-439-8856 Fax: 610-439-8856 | |
Muhammad Majeed, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-5369 | |
Allison Jane Baragona, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1501 N Cedar Crest Blvd Ste 110, Allentown, PA 18104 Phone: 610-821-2828 Fax: 610-821-7915 | |
James A Burke, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 300, Allentown, PA 18103 Phone: 610-402-3110 Fax: 610-402-3112 | |
Stephen R Shore, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1901 Hamilton St Ste 300, Allentown, PA 18104 Phone: 610-628-7900 Fax: 833-816-7513 | |
Tarika Sejal Chowdhary, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 17th & Chew, Suite 101, Allentown, PA 18105 Phone: 610-969-4370 | |
Ashley Vojtek, DO Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3200 |